Rankings
▼
Calendar
IOBT Q4 2024 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena
IOBT
IO Biotech, Inc.
$21M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$219,000
Operating Income
-$27M
Net Income
-$31M
EPS (Diluted)
$-0.48
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$68M
Total Liabilities
$21M
Stockholders' Equity
$47M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$219,000
-$201,000
-9.0%
Operating Income
-$27M
-$28M
+4.4%
Net Income
-$31M
-$26M
-19.7%
← FY 2024
All Quarters
Q1 2025 →